118 related articles for article (PubMed ID: 33675830)
1. ARID1A knockdown in human endothelial cells directly induces angiogenesis by regulating angiopoietin-2 secretion and endothelial cell activity.
Yoodee S; Peerapen P; Plumworasawat S; Thongboonkerd V
Int J Biol Macromol; 2021 Jun; 180():1-13. PubMed ID: 33675830
[TBL] [Abstract][Full Text] [Related]
2. Arid1a regulates response to anti-angiogenic therapy in advanced hepatocellular carcinoma.
Hu C; Li W; Tian F; Jiang K; Liu X; Cen J; He Q; Qiu Z; Kienast Y; Wang Z; Zhang H; Ji Y; Hu J; Hui L
J Hepatol; 2018 Mar; 68(3):465-475. PubMed ID: 29113912
[TBL] [Abstract][Full Text] [Related]
3. Knock-down of Pdcd4 stimulates angiogenesis via up-regulation of angiopoietin-2.
Krug S; Huth J; Göke F; Buchholz M; Gress TM; Göke R; Lankat-Buttgereit B
Biochim Biophys Acta; 2012 Apr; 1823(4):789-99. PubMed ID: 22289349
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenesis by lentivirus-mediated small interfering RNA silencing of angiopoietin-2 gene in pancreatic carcinoma.
Zhou J; Zhang ZX; Zhao H; Zhu DM; Zhang Y; Li DC
Technol Cancer Res Treat; 2011 Aug; 10(4):361-9. PubMed ID: 21728393
[TBL] [Abstract][Full Text] [Related]
5. lncRNA PVT1 promotes the angiogenesis of vascular endothelial cell by targeting miR‑26b to activate CTGF/ANGPT2.
Zheng J; Hu L; Cheng J; Xu J; Zhong Z; Yang Y; Yuan Z
Int J Mol Med; 2018 Jul; 42(1):489-496. PubMed ID: 29620147
[TBL] [Abstract][Full Text] [Related]
6. MEDI3617, a human anti-angiopoietin 2 monoclonal antibody, inhibits angiogenesis and tumor growth in human tumor xenograft models.
Leow CC; Coffman K; Inigo I; Breen S; Czapiga M; Soukharev S; Gingles N; Peterson N; Fazenbaker C; Woods R; Jallal B; Ricketts SA; Lavallee T; Coats S; Chang Y
Int J Oncol; 2012 May; 40(5):1321-30. PubMed ID: 22327175
[TBL] [Abstract][Full Text] [Related]
7. [Impact of biological function on ovarian clear cell carcinoma ES2 cell line with ARID1A gene expression down-regulating in vitro].
Lyu CS; Zhang YL; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2016 Mar; 51(3):209-15. PubMed ID: 27030501
[TBL] [Abstract][Full Text] [Related]
8. Angiopoietin-2 inhibition using siRNA or the peptide antagonist L1-10 results in antitumor activity in human neuroblastoma.
D'Souza SS; Scherzinger-Laude K; Simon M; Salimath BP; Rössler J
J Cancer Res Clin Oncol; 2012 Dec; 138(12):2017-26. PubMed ID: 22777681
[TBL] [Abstract][Full Text] [Related]
9. Early growth response-1 regulates angiopoietin-1-induced endothelial cell proliferation, migration, and differentiation.
Abdel-Malak NA; Mofarrahi M; Mayaki D; Khachigian LM; Hussain SN
Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):209-16. PubMed ID: 19112164
[TBL] [Abstract][Full Text] [Related]
10. IL-35 Inhibits Angiogenesis through VEGF/Ang2/Tie2 Pathway in Rheumatoid Arthritis.
Jiang S; Li Y; Lin T; Yuan L; Li Y; Wu S; Xia L; Shen H; Lu J
Cell Physiol Biochem; 2016; 40(5):1105-1116. PubMed ID: 27960151
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide (LPS)-mediated angiopoietin-2-dependent autocrine angiogenesis is regulated by NADPH oxidase 2 (Nox2) in human pulmonary microvascular endothelial cells.
Menden H; Welak S; Cossette S; Ramchandran R; Sampath V
J Biol Chem; 2015 Feb; 290(9):5449-61. PubMed ID: 25568324
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of ARID1A-interacting proteins in renal tubular cells and their molecular regulation of angiogenesis.
Yoodee S; Peerapen P; Plumworasawat S; Malaitad T; Thongboonkerd V
J Transl Med; 2023 Nov; 21(1):862. PubMed ID: 38017409
[TBL] [Abstract][Full Text] [Related]
13. Angiopoietin-2 TIEs up macrophages in tumor angiogenesis.
De Palma M; Naldini L
Clin Cancer Res; 2011 Aug; 17(16):5226-32. PubMed ID: 21576085
[TBL] [Abstract][Full Text] [Related]
14. Angiopoietin-2/Tie2 signaling involved in TNF-α induced peritoneal angiogenesis.
Yuan J; Fang W; Lin A; Ni Z; Qian J
Int J Artif Organs; 2012 Sep; 35(9):655-62. PubMed ID: 23065888
[TBL] [Abstract][Full Text] [Related]
15. miR-370 inhibits the angiogenic activity of endothelial cells by targeting smoothened (SMO) and bone morphogenetic protein (BMP)-2.
Gu Y; Becker V; Zhao Y; Menger MD; Laschke MW
FASEB J; 2019 Jun; 33(6):7213-7224. PubMed ID: 30865837
[TBL] [Abstract][Full Text] [Related]
16. Laminar shear inhibits tubule formation and migration of endothelial cells by an angiopoietin-2 dependent mechanism.
Tressel SL; Huang RP; Tomsen N; Jo H
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2150-6. PubMed ID: 17673702
[TBL] [Abstract][Full Text] [Related]
17. SMYD1, an SRF-Interacting Partner, Is Involved in Angiogenesis.
Ye X; Qian Y; Wang Q; Yuan W; Mo X; Li Y; Jiang Z; Xu W; Deng Y; Wan Y; Fan X; Wu X; Wang Y
PLoS One; 2016; 11(1):e0146468. PubMed ID: 26799706
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis.
Li C; Li Q; Cai Y; He Y; Lan X; Wang W; Liu J; Wang S; Zhu G; Fan J; Zhou Y; Sun R
Cancer Gene Ther; 2016 Sep; 23(9):295-302. PubMed ID: 27492854
[TBL] [Abstract][Full Text] [Related]
19. Int6/eIF3e silenced HIF2α stabilization enhances migration and tube formation of HUVECs via IL-6 and IL-8 signaling.
Endler A; Chen L; Li Q; Uchida K; Hashimoto T; Lu L; Xu GT; Shibasaki F
Cytokine; 2013 Apr; 62(1):115-22. PubMed ID: 23478175
[TBL] [Abstract][Full Text] [Related]
20. Utilizing combinatorial engineering to develop Tie2 targeting antagonistic angiopoetin-2 ligands as candidates for anti-angiogenesis therapy.
Shlamkovich T; Aharon L; Barton WA; Papo N
Oncotarget; 2017 May; 8(20):33571-33585. PubMed ID: 28422724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
